# Adjuvant Chemotherapy With Docetaxel, Capecitabine and Cisplatin in Patients With Advanced Gastric Cancer: Adjuvant DXP

> **NCT00976976** · PHASE2 · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 46 (actual)

## Conditions studied

- Resected Advanced Gastric Cancer

## Interventions

- **DRUG:** docetaxel, capecitabine, cisplatin

## Key facts

- **NCT ID:** NCT00976976
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2020-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00976976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00976976, "Adjuvant Chemotherapy With Docetaxel, Capecitabine and Cisplatin in Patients With Advanced Gastric Cancer: Adjuvant DXP". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00976976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*